233 related articles for article (PubMed ID: 11886434)
1. Transferrin toxin but not transferrin receptor immunotoxin is influenced by free transferrin and iron saturation.
Gosselaar PH; van-Dijk AJ; de-Gast GC; Polito L; Bolognesi A; Vooijs WC; Verheul AF; Krouwer HG; Marx JJ
Eur J Clin Invest; 2002 Mar; 32 Suppl 1():61-9. PubMed ID: 11886434
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
[TBL] [Abstract][Full Text] [Related]
3. A chimeric saporin-transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity.
Ippoliti R; Lendaro E; D'Agostino I; Fiani ML; Guidarini D; Vestri S; Benedetti PA; Brunori M
FASEB J; 1995 Sep; 9(12):1220-5. PubMed ID: 7672515
[TBL] [Abstract][Full Text] [Related]
4. Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis.
Bergamaschi G; Perfetti V; Tonon L; Novella A; Lucotti C; Danova M; Glennie MJ; Merlini G; Cazzola M
Br J Haematol; 1996 Jun; 93(4):789-94. PubMed ID: 8703804
[TBL] [Abstract][Full Text] [Related]
5. A comparison of anti-lymphocyte immunotoxins containing different ribosome-inactivating proteins and antibodies.
Bolognesi A; Tazzari PL; Tassi C; Gromo G; Gobbi M; Stirpe F
Clin Exp Immunol; 1992 Sep; 89(3):341-6. PubMed ID: 1516253
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.
Flavell DJ; Boehm DA; Noss A; Flavell SU
Br J Cancer; 1997; 75(7):1035-43. PubMed ID: 9083340
[TBL] [Abstract][Full Text] [Related]
7. Distinct cellular responses induced by saporin and a transferrin-saporin conjugate in two different human glioblastoma cell lines.
Cimini A; Mei S; Benedetti E; Laurenti G; Koutris I; Cinque B; Cifone MG; Galzio R; Pitari G; Di Leandro L; Giansanti F; Lombardi A; Fabbrini MS; Ippoliti R
J Cell Physiol; 2012 Mar; 227(3):939-51. PubMed ID: 21503892
[TBL] [Abstract][Full Text] [Related]
8. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
9. Selective lesions of rabbit extraocular muscles injected with the anti-AChR immunotoxin saporin-mAb 73.
Campos EC; Schiavi C; Bolognesi A; Bellusci C; Lubelli C; Duca A; Polito L; Poulas K; Tzartos SJ; Stirpe F
Curr Eye Res; 2002 Jan; 24(1):58-65. PubMed ID: 12187496
[TBL] [Abstract][Full Text] [Related]
10. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
Recht LD; Griffin TW; Raso V; Salimi AR
Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies.
Bolognesi A; Tazzari PL; Olivieri F; Polito L; Lemoli R; Terenzi A; Pasqualucci L; Falini B; Stirpe F
Br J Haematol; 1998 Apr; 101(1):179-88. PubMed ID: 9576199
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxins containing saporin 6 and monoclonal antibodies recognizing plasma cell-associated antigens: effects on target cells and on normal myeloid precursors (CFU-GM).
Barbieri L; Dinota A; Gobbi M; Tazzari PL; Rizzi S; Bontadini A; Lemoli RM; Tura S; Stirpe F
Eur J Haematol; 1989 Mar; 42(3):238-45. PubMed ID: 2784390
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice.
Terenzi A; Bolognesi A; Pasqualucci L; Flenghi L; Pileri S; Stein H; Kadin M; Bigerna B; Polito L; Tazzari PL; Martelli MF; Stirpe F; Falini B
Br J Haematol; 1996 Mar; 92(4):872-9. PubMed ID: 8616080
[TBL] [Abstract][Full Text] [Related]
14. Immunotoxins containing saporin linked to different CD2 monoclonal antibodies: in vitro evaluation.
Tazzari PL; Bolognesi A; De Totero D; Lemoli RM; Fortuna A; Conte R; Crumpton MJ; Stirpe F
Br J Haematol; 1994 Jan; 86(1):97-105. PubMed ID: 7912101
[TBL] [Abstract][Full Text] [Related]
15. Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
Flavell DJ; Flavell SU; Boehm DA; Emery L; Noss A; Ling NR; Richardson PR; Hardie D; Wright DH
Br J Cancer; 1995 Dec; 72(6):1373-9. PubMed ID: 8519647
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA
Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201
[TBL] [Abstract][Full Text] [Related]
17. The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine.
Polito L; Bolognesi A; Tazzari PL; Farini V; Lubelli C; Zinzani PL; Ricci F; Stirpe F
Leukemia; 2004 Jul; 18(7):1215-22. PubMed ID: 15103391
[TBL] [Abstract][Full Text] [Related]
18. Saporin 6 conjugated to monoclonal antibody selectively kills human melanoma cells.
Tecce R; Nicotra MR; Fraioli R; Cuomo M; Trizio D; Natali PG
Melanoma Res; 1991; 1(2):115-23. PubMed ID: 1823624
[TBL] [Abstract][Full Text] [Related]
19. High sensitivity of cultured human trophoblasts to ribosome-inactivating proteins.
Battelli MG; Montacuti V; Stirpe F
Exp Cell Res; 1992 Jul; 201(1):109-12. PubMed ID: 1612115
[TBL] [Abstract][Full Text] [Related]
20. An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells.
Tazzari PL; Barbieri L; Gobbi M; Dinota A; Rizzi S; Bontadini A; Pession A; Tura S; Stirpe F
Cancer Immunol Immunother; 1988; 26(3):231-6. PubMed ID: 3260131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
